ROS-Responsive Fluorinated Oxalate Nanomedicine for Dual Chemiluminescence/1⁹F MRI Imaging and Targeted Drug Release
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26073304 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anatoly Peshkov und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Materials Engineering, School of Engineering and Digital Sciences, Nazarbayev University, Astana 010000, Kazakhstan. Hauptthemen laut MEDLINE: Oxalates, Reactive Oxygen Species, Magnetic Resonance Imaging, Nanomedicine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan, Nazarbayev University.
Abstract (Originalsprache)
In this study, we developed a novel theranostic nanomedicine formulation that integrates multimodal imaging with controlled drug release in reactive oxygen species (ROS)-rich microenvironments. A fluorinated oxalate compound (FOC) was synthesized through a one-step condensation reaction between 1,1,1,3,3,3-hexafluoro-2-propanol and oxalyl chloride, characterized by 1H, 13C, and 1⁹F NMR spectroscopy. The FOC and luminophore-incorporated nanomedicine formulations reacted rapidly with hydrogen peroxide via the peroxyoxalate chemiluminescence (POCL) mechanism, producing strong chemiluminescence and inducing a notable 19-fold increase in ratiometric 1⁹F NMR signal upon conversion to fluorinated alcohol (FAH), demonstrating promising potential for high-contrast 1⁹F MRI in deep tissue. Following ROS stimulation, the chemical conversion from hydrophobic FOC to hydrophilic FAH led to the degradation of the nanomedicines, facilitating payload release. In vitro experiments with A-431 cancer cells under hypoxic conditions confirmed ROS-responsive drug release, evidenced by enhanced fluorescence from model luminophores. Additionally, doxorubicin-loaded FOC nanomedicines reduced cell viability to 32% under hypoxia while remaining non-toxic in normoxic conditions. These results indicate that FOC-based nanomedicine formulations provide a promising platform for combined chemiluminescence and 1⁹F MRI with targeted therapeutic efficacy in ROS-rich inflammatory and cancerous tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Materials Engineering, School of Engineering and Digital Sciences, Nazarbayev University, Astana 010000, Kazakhstan.
- National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.
- Department of Chemistry, School of Science and Humanities, Nazarbayev University, Astana 010000, Kazakhstan.
- Department of Biology, School of Science and Humanities, Nazarbayev University, Astana 010000, Kazakhstan.
ORCID-Profile: Anatoly Peshkov, Nasir Bala Alhassan, Almaz Beisenbayev, Yerkin Shabdan, Bauyrzhan Umbayev, Timur Elebessov, Tri Thanh Pham, Chang-Keun Lim
Förderung
- Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan
- Nazarbayev University
Zitieren
APA
Peshkov, A., Urazaliyeva, A., Saiduldinova, D., Kulbergenov, K., Alhassan, N. B., Beisenbayev, A., Shabdan, Y., Umbayev, B., Peshkov, V., Atabaev, T. S., Elebessov, T., Pham, T. T., & Lim, C. K. (2025). ROS-Responsive Fluorinated Oxalate Nanomedicine for Dual Chemiluminescence/1⁹F MRI Imaging and Targeted Drug Release. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073304
Vancouver
Peshkov A, Urazaliyeva A, Saiduldinova D, Kulbergenov K, Alhassan NB, Beisenbayev A, et al. ROS-Responsive Fluorinated Oxalate Nanomedicine for Dual Chemiluminescence/1⁹F MRI Imaging and Targeted Drug Release. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073304
BibTeX
@article{Peshkov2025,
author = {Peshkov, Anatoly and Urazaliyeva, Anel and Saiduldinova, Dariyana and Kulbergenov, Kazbek and Alhassan, Nasir Bala and Beisenbayev, Almaz and Shabdan, Yerkin and Umbayev, Bauyrzhan and Peshkov, Vsevolod and Atabaev, Timur Sh and Elebessov, Timur and Pham, Tri Thanh and Lim, Chang-Keun},
title = {ROS-Responsive Fluorinated Oxalate Nanomedicine for Dual Chemiluminescence/1⁹F MRI Imaging and Targeted Drug Release},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26073304}
}
EUVIMED